Abiopharma

Form 8.3

TotalEnergies SE: Ordinary and Extraordinary Shareholders’ Meeting on May 29, 2026

TotalEnergies SE: Ordinary and Extraordinary Shareholders’ Meeting on May 29, 2026

TotalEnergies SE : Assemblée générale ordinaire et extraordinaire du 29 mai 2026

(30% Negative) HOLLEY INC. (HLLY) Reports Q2 2026 Financial Results

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): DISCLOSURE OF CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER-Q & M DENTAL GROUP (SINGAPORE) LIMITED

(10% Negative) MEDLINE INC. (MDLN) Reports Q2 2026 Financial Results

(30% Negative) 908 DEVICES INC. (MASS) Reports Q2 2026 Financial Results

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 0001213900-26-052618 <b>Size:</b> 47 KB

Oelwang Jean 🟡 adjusted position in 195.9K shares (1 derivative) of NOVONIX Ltd (NVX) Transaction Date: May 06, 2026 | Filing ID: 207588

General Announcement: Issue and Allotment of Shares pursuant to exercise of Warrants

DocGo Announces Upcoming Participation at the 21st Annual Needham Technology, Media, & Consumer Conference

Capstone Publishes Investor FAQ Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 Guidance

New Form SCHEDULE 13D - Churchill Capital Corp XII <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 0001213900-26-052616 <b>Size:</b> 40 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Changes in Interest of Director - Yong Jiunn Run